Showing posts with label pancreas. Show all posts
Showing posts with label pancreas. Show all posts

Friday, 29 June 2018

Pancreatic cell size linked to mammalian lifespan, finds zoo animal analysis


June 18, 2018, Cell Press

More than two thousand years ago, Greek philosopher Aristotle observed that larger animals tend to live longer than smaller ones. On June 18 in the journal Developmental Cell, scientists report that it's cell size, not body size, that intrinsically correlates with and perhaps affects lifespan. By examining the pancreases of 24 mammalian species—including shrews, humans, and tigers—researchers in Israel, Canada, and Germany found that animals with larger pancreatic cells tend to age faster, while smaller cells seem to go hand in hand with longer lifespans.

"That there was a correlation between two things that are so remote was shockingly beautiful and unexpected," says senior author Yuval Dor, who studies developmental biology at the Institute for Medical Research Israel-Canada and The Hebrew University-Hadassah Medical School in Jerusalem.

"This study has exposed a trend that seems to transcend all animal life," says co-author Ran Kafri, a computational biologist at the University of Toronto and the Hospital for Sick Children in Canada. "It demonstrates that there's a property that can be measured on a single cell that predicts the lifespan of a whole animal."

Scientists had thought that after birth, most mammals' organs, including the pancreas, grow by cell proliferation. However, Dor, Kafri, and colleagues made a serendipitous observation; they needed a higher magnification to look at pancreatic cells of new-born mice through a microscope than they did to look at those of adults, suggesting that each cell's volume was substantially increasing from infant to adult life.

Repeated measurements showed that the growth of individual exocrine pancreatic cells, known as acinar cells, is responsible for much of the overall organ growth after birth. "This was surprising because the assumption was that postnatally, the pancreas grows by increasing the number of cells just like most organs that we think about," says Dor.


Read more at: 

Saturday, 12 May 2012

What Do Marine Snails and Insulin Have in Common? New Approach to Treat Diabetes?



ScienceDaily (May 10, 2012) — The cone snails are predators of the sea. They capture fish by injecting a venom into the prey that consists of a cocktail of different substances. The single components of the snails' venom, so-called conopeptides, are known for their extraordinary pharmacological properties and potential.

One example is Ziconotid (Prialt), a conopeptide that is prescribed as a pain medicine. That makes it one of the first medicines to contain substances from marine organisms. In collaboration with scientists from Canada and the USA, research teams at the Universities of Kiel, Lübeck, and Göttingen have examined the venom of the cone snail Conus striatus. They were able to demonstrate that a certain peptide (Conkunitzin-S1) alters the release of insulin in the pancreas cells. Their findings were recently published in the scientific magazine EMBO Molecular Medicine.

"This potentially could be a new approach to the treatment of type 2 diabetes," says Professor Heinrich Terlau from the Physiological Institute of Kiel University and associate member of the Excellence Cluster "Future Ocean." "The action of some substances that are ordinarily used in the treatment of type 2 diabetes is independent of the blood glucose level," Terlau describes. This can lead to low blood glucose, also known as hypoglycemia. "What is new about this substance is that it has a very specific effect. Because of this fact, the likelihood of side effects such as hypoglycemia is minimal," Terlau continues.


Related Posts with Thumbnails

ShareThis